AllianceBernstein’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRMD
CCM
VCM
NTCM
AllianceBernstein's IRMD Position: Q1 2026 in Review
AllianceBernstein increased its iRadimed (IRMD) stake by 122% in Q1 2026, buying an estimated $1.13M and bringing the position to 20,572 shares worth $2M. The position accounts for ﹤0.01% of the portfolio, ranked #2008.
AllianceBernstein first reported a position in IRMD in Q1 2020 and has held it in 25 quarters since. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.
- AllianceBernstein held 20,572 shares of iRadimed worth $2M as of Q1 2026.
- AllianceBernstein bought 11,310 iRadimed shares in Q1 2026, an estimated $1.13M.
- iRadimed made up ﹤0.01% of AllianceBernstein's portfolio in Q1 2026, its #2008 holding.
- AllianceBernstein first reported a position in iRadimed in Q1 2020 and has held it in 25 quarters since.
- 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.
Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.